Oppenheimer & Co’s FT Vest US Equity Deep Buffer ETF October DOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7M Buy
400,877
+2,617
+0.7% +$120K 0.2% 93
2026
Q1
$17.3M Buy
398,260
+1,924
+0.5% +$85.2K 0.21% 92
2025
Q4
$17.6M Buy
396,336
+376,336
+1,882% +$16.5M 0.25% 76
2025
Q3
$864K Hold
20,000
0.01% 964
2025
Q2
$821K Hold
20,000
0.01% 946
2025
Q1
$767K Hold
20,000
0.01% 918
2024
Q4
$787K Buy
+20,000
New +$787K 0.01% 895

Other funds holding DOCT

Oppenheimer & Co's DOCT Position: Q2 2026 in Review

Oppenheimer & Co increased its FT Vest US Equity Deep Buffer ETF October (DOCT) stake by 0.66% in Q2 2026, buying an estimated $120K and bringing the position to 400,877 shares worth $18.7M. The position accounts for 0.2% of the portfolio, ranked #93.

Oppenheimer & Co first reported a position in DOCT in Q4 2024 and has held it in 7 quarters since. 108 funds tracked by Wall St. Rank hold DOCT as of Q2 2026.

  • Oppenheimer & Co held 400,877 shares of FT Vest US Equity Deep Buffer ETF October worth $18.7M as of Q2 2026.
  • Oppenheimer & Co bought 2,617 FT Vest US Equity Deep Buffer ETF October shares in Q2 2026, an estimated $120K.
  • FT Vest US Equity Deep Buffer ETF October made up 0.2% of Oppenheimer & Co's portfolio in Q2 2026, its #93 holding.
  • Oppenheimer & Co first reported a position in FT Vest US Equity Deep Buffer ETF October in Q4 2024 and has held it in 7 quarters since.
  • 108 funds tracked by Wall St. Rank held FT Vest US Equity Deep Buffer ETF October as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.